MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1681 to 1700 of 166,322 approvalsPage 85 of 8317

Tadalafil Tablets

Approval Number: 国药准字H20258010
Registration: Jan 14, 2025
湖南千金湘江药业股份有限公司

Oseltamivir Phosphate Granules

Approval Number: 国药准字H20253139
Registration: Jan 14, 2025
成都第一制药有限公司

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number: 国药准字H20253199
Registration: Jan 14, 2025
浙江永太药业有限公司

Pregabalin Capsules

Approval Number: 国药准字H20253180
Registration: Jan 14, 2025
浙江昂利康制药股份有限公司

Oxazepam Tablets

Approval Number: 国药准字H20253141
Registration: Jan 14, 2025
湖南洞庭药业股份有限公司

Desloratadine Tablets

Approval Number: 国药准字HJ20250011
Registration: Jan 14, 2025
MYLAN LABORATORIES LIMITED

Apalutamide Tablets

Approval Number: 国药准字H20253127
Registration: Jan 14, 2025
四川科伦药业股份有限公司

Lidocaine Hydrochloride Injection

Approval Number: 国药准字H20253207
Registration: Jan 14, 2025
江苏长江药业有限公司

Vortioxetine Hydrobromide Tablets

Approval Number: 国药准字H20253191
Registration: Jan 14, 2025
武汉童学文化股份有限公司

Esomeprazole Sodium for Injection

Approval Number: 国药准字H20253142
Registration: Jan 14, 2025
海南葫芦娃药业集团股份有限公司

Famotidine Injection

Approval Number: 国药准字H20253218
Registration: Jan 14, 2025
云南药科院生物医药股份有限公司

Senaparib Capsules

Approval Number: 国药准字H20250002
Registration: Jan 14, 2025
上海英派药业有限公司

Pheniramine Maleate Naphazoline Hydrochloride Eye Drops

Approval Number: 国药准字H20253223
Registration: Jan 14, 2025
广州大光制药有限公司

Nicergoline Tablets

Approval Number: 国药准字H20253174
Registration: Jan 14, 2025
北京九能天远科技有限公司

Biapenem for Injection

Approval Number: 国药准字H20253173
Registration: Jan 14, 2025
安徽省先锋制药有限公司

Mirabegron Sustained-release Tablets

Approval Number: 国药准字H20253163
Registration: Jan 14, 2025
乐泰药业有限公司

Roxatidine Acetate Hydrochloride For Injection

Approval Number: 国药准字H20253155
Registration: Jan 14, 2025
广东众生药业股份有限公司

Methotrexate Tablets

Approval Number: 国药准字H20253213
Registration: Jan 14, 2025
国药一心制药有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.